Article info

Download PDFPDF
Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes

Authors

  • Sylvie Julien Section of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Tuebingen, Germany Preclinical Drug Assessment, STZ OcuTox, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Antje Biesemeier Section of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Tatjana Taubitz Section of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Tuebingen, Germany Preclinical Drug Assessment, STZ OcuTox, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Ulrich Schraermeyer Section of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Tuebingen, Germany Preclinical Drug Assessment, STZ OcuTox, Tübingen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ulrich Schraermeyer, Section of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Schleichstrasse 12/1, Tuebingen 72076, Germany; Ulrich.Schraermeyer{at}med.uni-tuebingen.de
View Full Text

Citation

Julien S, Biesemeier A, Taubitz T, et al
Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes

Publication history

  • Received July 16, 2013
  • Revised December 20, 2013
  • Accepted December 23, 2013
  • First published January 23, 2014.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.